Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) Price Target at $21.93

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have received an average rating of “Hold” from the eighteen analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $22.00.

Several research analysts recently issued reports on the stock. UBS Group decreased their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, May 20th. TD Cowen upped their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Weiss Ratings cut Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, June 2nd. Finally, Wells Fargo & Company upped their price target on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Tuesday.

Bath & Body Works Stock Up 5.1%

BBWI opened at $22.94 on Monday. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $33.96. The stock has a market cap of $4.62 billion, a PE ratio of 6.44, a PEG ratio of 2.16 and a beta of 1.42. The business has a 50 day moving average of $19.14 and a 200-day moving average of $20.28.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities analysts anticipate that Bath & Body Works will post 2.62 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s payout ratio is 22.47%.

Hedge Funds Weigh In On Bath & Body Works

Institutional investors and hedge funds have recently modified their holdings of the stock. Chase Investment Counsel Corp purchased a new position in Bath & Body Works in the fourth quarter worth about $1,606,000. SG Americas Securities LLC grew its holdings in shares of Bath & Body Works by 725.3% during the fourth quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock valued at $9,364,000 after buying an additional 409,831 shares during the last quarter. Wedge Capital Management L L P NC raised its holdings in Bath & Body Works by 49.9% in the 4th quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock worth $4,304,000 after acquiring an additional 71,349 shares during the last quarter. Champlain Investment Partners LLC lifted its position in Bath & Body Works by 51.5% in the 3rd quarter. Champlain Investment Partners LLC now owns 1,940,685 shares of the company’s stock valued at $49,992,000 after acquiring an additional 659,799 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. boosted its stake in Bath & Body Works by 27.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,132,245 shares of the company’s stock valued at $42,815,000 after purchasing an additional 458,620 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.